Observations from a statin myopathy clinic [2]

Archives of Internal Medicine

Volumn 166, Issue 11, 2006, Pages 1232-1233

  Phillips, Paul S ^a   Haas, Richard H ^b  

^a SCRIPPS MERCY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN;

GAS EXCHANGE; HUMAN; LETTER; METABOLIC DISORDER; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE EXERCISE; MYOPATHY; PRIORITY JOURNAL;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCULAR DISEASES;

EID: 33745010871     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.11.1232-b     Document Type: Letter

References (6)

1. Hansen KE, Hildebrand JP, Ferguson EE, Stein JH. Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med. 2005;165:2671-2676.
2. Kordas KC, Phillips PS, Golomb BA. Clinical characteristics of 1053 patients with statin associated muscle complaints [abstract]. Arteriosclero Thromb Vasc Biol. 2004;24:e51-e136.
3. Phillips PS, Phillips CT, Sullivan M, Naviaux RK, Haas RH. Statin motoxicity is associated with changes in cardiopulmonary function. Atherosclerosis. 2004;177:183-188.
4. Vladutiu GD, Isackson PJ. The relationship between metabolic muscle diseases and cholesterol-lowering drugs [abstract]. Mol Genet Metab. 2004;81:157.
5. Phillips PS, Haas RH, Bannykh S, et al; Scripps Mercy Clinical Research Center. Statin associated myopathy with normal creatine kinase. Ann Intern Med. 2002;137:581-585.
6. Golomb BA, Yang E, Denenberg J, Criqui M. Statin-associated adverse effects. Circulation. 2003;107:e7028-e7029.